| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5290832
Max Phase: Preclinical
Molecular Formula: C9H7NOS
Molecular Weight: 177.23
Associated Items:
Representations
Canonical SMILES: On1cc2ccccc2cc1=S
Standard InChI: InChI=1S/C9H7NOS/c11-10-6-8-4-2-1-3-7(8)5-9(10)12/h1-6,11H
Standard InChI Key: JVOLHASWMRPTKQ-UHFFFAOYSA-N
Associated Targets(non-human)
Polymerase acidic protein 806 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 177.23 | Molecular Weight (Monoisotopic): 177.0248 | AlogP: 2.61 | #Rotatable Bonds: 0 |
| Polar Surface Area: 25.16 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.07 | CX Basic pKa: | CX LogP: 1.09 | CX LogD: 1.01 |
| Aromatic Rings: 2 | Heavy Atoms: 12 | QED Weighted: 0.49 | Np Likeness Score: -0.36 |
References
| 1. Arshad JZ, Hanif M.. (2022) Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors., 13 (10.0): [PMID:36325396] [10.1039/d2md00175f] |
Source
Source(1):